Skip to main content
. 2023 Jun 12;9(3):101241. doi: 10.1016/j.jvscit.2023.101241

Supplementary Table.

Periprocedural (30-day) serious adverse eventsa

Serious adverse event Device relatedb Procedure relatedb Time after procedure,c days Statusd
Hyperglycemia No Yes 0 Resolved without sequelae
Arrhythmia No Yes 1 Resolved without sequelae
Postimplantation syndrome Yes No 1 Resolved without sequelae
Fever Yes No 1 Resolved without sequelae
Constipation No Yes 2 Resolved without sequelae
Low hemoglobin No Yes 2 Resolved with sequelae
Postimplantation syndrome Yes No 3 Resolved without sequelae
Abdominal pain No Yes 5 Resolved without sequelae
a

Serious according to ISO 14155:2020 Clinical investigation of medical devices for human subjects – good clinical practice.

b

Probably or more likely related to the study device or study procedure, which was adjudicated by a medical monitor independently of the study investigators.

c

Day 0 is the day of procedure.

d

Status at last follow-up.